CNS market to surpass $80 bn in 2025, driven by MS and psychiatric drug innovation: GlobalData
The revival of CNS drug development is being fueled by advancements in neuroimmunology and neurodegeneration, moving beyond…
Recover your password.
A password will be e-mailed to you.